A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy

Diabetic Medicine

Volumn 30, Issue 5, 2013, Pages 525-534

  Papanas, N ^a   Boulton, A J M ^b,c   Malik, R A ^b   Manes, C ^d   Schnell, O ^e   Spallone, V ^f   Tentolouris, N ^g   Tesfaye, S ^h   Valensi, P ⁱ   Ziegler, D ^j   Kempler, P ^k  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g UNIVERSITY OF ATHENS   (Greece)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ UNIVERSITÉ PARIS 13   (France)

^j UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^k SEMMELWEIS UNIVERSITY   (Hungary)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLOR; CORRELATION ANALYSIS; DIABETIC CARDIAC AUTONOMIC NEUROPATHY; DIABETIC NEUROPATHY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; REPRODUCIBILITY; REVIEW; SELF EXAMINATION; SENSITIVITY AND SPECIFICITY; SWEAT TEST;

AMPUTATION; BIOLOGICAL MARKERS; DIABETIC FOOT; EARLY DIAGNOSIS; FEMALE; HUMANS; INDICATORS AND REAGENTS; MALE; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENSORY THRESHOLDS; SWEAT;

EID: 84876361101     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12000     Document Type: Review

References (50)

1. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-962.
2. Várkonyi T, Kempler P. Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 2008; 10: 99-108.
3. Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004; 47: 1343-1353.
4. Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?Diabetes Care 2002; 25: 2010-2015.
5. Ziegler D, Zentai CP, Perz S, Rathmann W, Haastert B, Doring A et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and non-diabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care 2008; 31: 556-561.
6. American Diabetes Association and American Academy of Neurology. Report and recommendations of the San Antonio conference on diabetic neuropathy. Consensus statement. Diabetes 1988; 37: 1000-1004.
7. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293.
8. Herman WH, Kennedy L. Underdiagnosis of peripheral neuropathy in type2 diabetes. Diabetes Care 2005; 28: 1480-1481.
9. Papanas N, Ziegler D. New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complications 2011; 25: 44-51.
10. Schnell O, Müller M, Standl E. Early detection of changes in the feet of diabetic patients with indicator test Neuropad. Diabetes Metab Heart 2008; 17: 203-210.
11. Young JA. Cobalt(ii) chloride hexahydrate. J Chem Educ 2003; 80: 610.
12. Zick R, Schäper T, Deeters U. Early detection of peripheral neuropathy. Measurement of perspiration in the diabetic foot. Klinikarzt 2003; 32: 192-194.
13. ®) in the diagnosis of peripheral neuropathy in type2 diabetic patients. Exp Clin Endocrinol Diabetes 2005; 113: 195-198.
14. Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve 2006; 34: 57-61.
15. Provitera V, Nolano M, Caporaso G, Stancanelli A, Santoro L, Kennedy WR. Evaluation of sudomotor function in diabetes using the dynamic sweat test. Neurology 2010; 74: 50-56.
16. Hoeldtke RD, Bryner KD, Horvath GG, Phares RW, Broy LF, Hobbs GR. Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type1 diabetes. Diabetes 2001; 50: 436-443.
17. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 2009; 26: 302-305.
18. Tentolouris N, Voulgari C, Liatis S, Kokkinos A, Eleftheriadou I, Makrilakis K et al. Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes. Diabetes Care 2010; 33: 1112-1124.
19. Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008; 31: 1679-1685.
20. Kempler P, Amarenco G, Freeman R, Frontoni S, Horowitz M, Stevens M et al. Gastrointestinal autonomic neuropathy, erectile, bladder and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis and management. Diabetes Metab Res Rev 2011; 27: 665-677.
21. Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E. The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type2 diabetes. Diabetes Educ 2007; 33: 257-266.
22. Spallone V, Morganti R, Siampli M, Fedele T, D'Amato C, Cacciotti L et al. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet Med 2009; 26: 686-692.
23. Papanas N, Paschos P, Papazoglou D, Papatheodorou K, Paletas K, Maltezos E et al. Accuracy of the neuropad test for the diagnosis of distal symmetric polyneuropathy in type2 diabetes. Diabetes Care 2011; 34: 1378-1382.
24. Ziegler D, Papanas N, Roden M; for the GDC Study Group. Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabet Med 2011; 28: 1412-1415.
25. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.
26. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G et al.A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care 1997; 20: 836-843.
27. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population. Diabetologia 1993; 36: 150-154.
28. Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 2007; 21: 353-358.
29. Liatis S, Marinou K, Tentolouris N, Pagoni S, Katsilambros N. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med 2007; 24: 1375-1380.
30. Shen J, Cao Y, Han YJ, Luo XR, Xie CH, Li JM et al. Sweat function evaluation for early diagnosis of diabetic peripheral neuropathy. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1210-1212.
31. Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJ, Malik RA. The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia 2008; 51: 1046-1050.
32. Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type2 diabetes. Exp Clin Endocrinol Diabetes 2008; 116: 135-138.
33. Freitas C, Carvalho A, Melo-Rocha G, Amaral C, Pinto S, Guimarães R et al. The Neuropad test in the screening of peripheral neuropathy in diabetic patients. Acta Med Port 2009; 22: 729-734.
34. Kamenov ZA, Petrova JJ, Christov VG. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (Neuropad) tests in the clinical practice. Exp Clin Endocrinol Diabetes 2010; 118: 226-233.
35. Ziegler D, Papanas N, Heier M, Rathmann W, Scheer M, Meisinger C; KORA Study Group. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and prediabetes. The KORA F4 survey. Diabetologia 2011; 54: A177.
36. Tentolouris N, Achtsidis V, Marinou K, Katsilambros N. Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 2008; 31: 236-237.
37. Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Maltezos E. A prospective study on the use of the indicator test Neuropad for the early diagnosis of peripheral neuropathy in type2 diabetes. Exp Clin Endocrinol Diabetes 2011; 119: 122-125.
38. Tentolouris N, Kokkinos A, Diakoumopoulou E, Eleftheriadou I, Alexiadou K. The association between Neuropad testing with peripheral neuropathy in diabetes: a meta-analysis. Diabetologia 2011; 54: A1154.
39. Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D et al. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type2 diabetic patients. Exp Clin Endocrinol Diabetes 2007; 115: 58-61.
40. Manes C, Kirlaki E, Papantoniou S, Sossidou E, Skoutas D, Tsotoulidis S et al. Validation of a new skin test as a screening tool in identifying patients with peripheral nerve dysfunction and at risk for foot ulceration: a multicenter study. Diabetes 2008; Suppl.: 238-OR.
41. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27: 639-653.
42. Chon S, Kiml Y-S, Ohl S, Wool J-T, Kim S-W, Kirn J-W et al. Assessment of diabetic autonomic neuropathy in type2 diabetic patients using Neuropad: a new indicator plaster for detection of disturbed sweat secretion. Diabetologia 2005; 48: A996.
43. Bilen H, Atmaca A, Akcay G. Neuropad indicator test for diagnosis of sudomotor dysfunction in type2 diabetes. Adv Ther 2007; 24: 1020-1027.
44. Didangelos TP, Zografou I, Papageorgiou A, Koukourikou M, Athyros V, Kontotasios K et al. Validation of a new diabetic autonomic neuropathy bedside test (plaster) versus the cardiovascular reflex tests. Diabetologia 2006; 49: A1107.
45. Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type2 diabetes mellitus: short communication. Exp Clin Endocrinol Diabetes 2005; 113: 577-581.
46. Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Maltezos E. Association between foot temperature and sudomotor dysfunction in type2 diabetes. J Diabetes Sci Technol 2010; 4: 803-807.
47. Tavakoli M, Quattrini C, Begum P, Fadavi H, Boulton AJM, Malik RA. Neuropad and corneal confocal microscopy: new indicators for human diabetic neuropathy. Diabetologia 2010; 53: A1112.
48. Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, Efron N et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003; 46: 683-688.
49. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002; 19: 377-384.
50. Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 2011; 7: 682-690.